Approval · Notice of Compliance 27883 · 2022
COLD + SINUS PLUS: Notice of Compliance 27883
Issued March 31, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27883
- Date
- March 31, 2022
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of private label brand mockups to comply with Plain Language Labelling
- Canadian reference product
- ADVIL COLD & SINUS PLUS (Glaxosmithkline Consumer Healthcare Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COLD + SINUS PLUS | 02359243 | Marketed |
Medicinal ingredients
- CHLORPHENIRAMINE MALEATE 2 MG per TAB
- IBUPROFEN 200 MG per TAB
- PSEUDOEPHEDRINE HCL 30 MG per TAB